NCT06465914 2024-12-12A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese MalesShanghai Bovax Biotechnology Co., Ltd.Phase 3 Active not recruiting9,000 enrolled
NCT05662020 2022-12-27A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in ChinaBeijing Health Guard Biotechnology, IncPhase 3 Active not recruiting2,750 enrolled
NCT01651949 2018-11-27Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)Merck Sharp & Dohme LLCPhase 3 Completed2,520 enrolled 13 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts